Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity


Trislan-Noguero A., Borras E., Molero-Luis M., Wassenberg T., Peters T., Verbeek M. M. , ...Daha Fazla

MOVEMENT DISORDERS, 2020 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası:
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1002/mds.28362
  • Dergi Adı: MOVEMENT DISORDERS

Özet

Background Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia.